Is a Correction Looming Ahead for Atossa Therapeutics Inc. (ATOS) – News Heater
Home  »  Hot Stocks   »  Is a Correction Looming Ahead for Atossa Therapeut...

Is a Correction Looming Ahead for Atossa Therapeutics Inc. (ATOS)

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Atossa Therapeutics Inc. (NASDAQ:ATOS) went down by -3.19% from its latest closing price compared to the recent 1-year high of $9.80. The company’s stock price has collected -2.26% of loss in the last five trading sessions. Press Release reported on 09/30/21 that Atossa Therapeutics Begins Enrollment in Clinical Study of AT-H201 in Australia

Is It Worth Investing in Atossa Therapeutics Inc. (NASDAQ :ATOS) Right Now?

Plus, the 36-month beta value for ATOS is at 2.22. Opinions of the stock are interesting as 2 analysts out of 2 who provided ratings for Atossa Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


The average price from analysts is $7.75. Today, the average trading volume of ATOS was 9.40M shares.

ATOS’s Market Performance

ATOS stocks went down by -2.26% for the week, with a monthly drop of -13.43% and a quarterly performance of -52.28%, while its annual performance rate touched 34.67%. The volatility ratio for the week stands at 5.08% while the volatility levels for the past 30 days are set at 6.14% for Atossa Therapeutics Inc.. The simple moving average for the period of the last 20 days is -7.61% for ATOS stocks with a simple moving average of -6.15% for the last 200 days.

Analysts’ Opinion of ATOS

Many brokerage firms have already submitted their reports for ATOS stocks, with Maxim Group repeating the rating for ATOS by listing it as a “Buy.” The predicted price for ATOS in the upcoming period, according to Maxim Group is $2 based on the research report published on January 26th of the previous year 2018.

ATOS Trading at -10.29% from the 50-Day Moving Average

After a stumble in the market that brought ATOS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -69.08% of loss for the given period.

Volatility was left at 6.14%, however, over the last 30 days, the volatility rate increased by 5.08%, as shares sank -7.06% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +4.12% upper at present.

During the last 5 trading sessions, ATOS fell by -2.26%, which changed the moving average for the period of 200-days by +242.76% in comparison to the 20-day moving average, which settled at $3.27. In addition, Atossa Therapeutics Inc. saw 218.95% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at ATOS starting from WEAVER GREGORY L, who sale 107,497 shares at the price of $5.58 back on Jul 02. After this action, WEAVER GREGORY L now owns 0 shares of Atossa Therapeutics Inc., valued at $599,833 using the latest closing price.

Stock Fundamentals for ATOS

The total capital return value is set at -72.33, while invested capital returns managed to touch -88.40. Equity return is now at value -32.70, with -30.50 for asset returns.

Based on Atossa Therapeutics Inc. (ATOS), the company’s capital structure generated 0.07 points at debt to equity in total, while total debt to capital is 0.07.

>> 7 Top Picks for the Post-Pandemic Economy <<

The liquidity ratio also appears to be rather interesting for investors as it stands at 2.73.

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam